| Revenue Growth | EM EBITDA up 20% excluding Micromax; Acetyls seeing Q4 seasonal declines. |
|---|---|
| Mgmt Confidence | Confident in $700-$800 million free cash flow despite dynamic macro environment. |
| Demand Visibility | Order book for late November/December matches 6-7% seasonal volume decline forecast. |
| Order Book | EM volume decline of 6-7% baked into Q4 guidance. |
| Margin Trends | Acetyls margin compression expected in Q4; EM offsetting costs with pricing. |
| Op. Leverage | Lannocken shutdown to provide two-thirds of cost savings in 2027. |
| Pricing Power | Pushing price increases in EM to offset rising methanol and energy costs. |
| Vol vs Price | Growth led by mix and pricing in EM; volumes down in China. |
| Segment Growth | Electronics and Medical outperforming; Automotive lagging due to China build declines. |
| New Clients | Nutrenova JV partnership with Mitsui; robotics collaboration with unnamed chemical leader. |
| Capex & Debt | CAPEX $300-$350 million; $150 million Nutrenova proceeds; $40 million interest savings. |
| Regulatory | Unplanned government inspections causing supplier outage in China. |
| Commentary | Emphasizing 'next generation productivity' using AI for raw material and energy efficiency. |
| New Launches | Three EM projects commercializing H1 2027; new European emulsions reactor added. |
Growth
Engineered Materials EBITDA grew 15-20% year-over-year; electronics and medical are primary growth drivers.
Outlook
Targeting $100 million in cost/interest savings and $300-$350 million CAPEX for 2027.
Risks
Management pivoted on specific 2027 EBITDA targets, citing uncertainty and potential margin compression in Acetyls.
The company's earnings call, NYSE: CE, and its 8-K filed with the SEC. Summary written with AI assistance from the call.
Earnings call webcast ↗ Watch on YouTube ↗
Celanese Corp: key numbers
- Share price
- $48.96Close, Nov 16
- Market cap
- $5.37B
- Shares outstanding
- 109.75MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Plastic Material, Synth Resin/Rubber, Cellulos (No Glass)SIC 2820
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Celanese Corp
All →Celanese Leadership Change
Celanese Corporation has elected Peter Matt to its Board of Directors, increasing the board size from 11 to 12 members. Mr. Matt currently serves as the President and CEO of Commercial Metals Company and brings over 40 years of experience in finance and global manufacturing leadership. He is expected to stand for re-election at the company's 2027 Annual Meeting of Shareholders.
Celanese Q3 2026 Results: Turns Profitable, Net Income $74M
Celanese Corp reported net sales of $2,556 million for the third quarter of 2026, a slight increase from $2,419 million in the prior year period. The company returned to profitability with net earnings of $78 million compared to a net loss of $1,353 million in Q3 2025, which had been impacted by significant other charges.
- Key figure
- Net income $74M
Celanese Earnings Call: Key Takeaways
Celanese focuses on cost-cutting and high-margin segments like medical and electronics to offset automotive weakness and Asian supply length, targeting $700-$800 million in free cash flow for 2027.
Celanese Financial Results
Celanese Corporation reported Q3 2026 adjusted earnings of $1.65 per share, a 23% increase year-over-year, and generated $461 million in free cash flow. The company highlighted strategic progress including the closure of its Lanaken acetate tow facility and the pending sale of an additional 19% interest in the Nutrinova joint venture for $152 million.
- Term
- Q3 2026
“Today, we reported third quarter 2026 adjusted earnings per share of $1.65 (inclusive of approximately $0.36 per share of non-cash transaction amortization), representing a 23 percent increase compared to the same period last year. I am also pleased to report that we generated $461 million of free cash flow in the quarter.”
Scott Richardson, Celanese Corporation, President and Chief Executive Officer
“Over the last two years, we have taken significant actions to improve the company's competitiveness, earnings quality, and cash generation. As a result, we expect to generate more than $1.5 billion in free cash flow across 2025 and 2026, demonstrating our ability to drive strong financial performance while making meaningful progress on deleveraging.”
Scott Richardson, Celanese Corporation, President and Chief Executive Officer
Celanese Financial Results
Celanese Corporation reported third quarter 2026 financial results, exceeding its previous guidance with net sales of $2.6 billion, a 6% increase year-over-year. The company generated $461 million in free cash flow during the quarter and raised its full-year outlook based on productivity actions and strategic growth initiatives.
“Our third quarter results demonstrate continued progress across Celanese, with strong earnings performance and net sales growth. Cash generation in the third quarter was strong, and by the end of 2026 we expect to have generated over $1.5 billion in free cash flow over the past two years, reflecting the benefits of the significant actions we have taken to improve productivity, strengthen commercial execution and enhance the quality of our portfolio.”
Scott Richardson, president and chief executive officer
“We also continue to advance our objective of generating approximately $1 billion of divestiture sales proceeds by the end of 2027, and expect to reach approximately $650 million by year end. The benefits of our productivity actions and early contributions from strategic growth initiatives are increasingly evident in our results, enhancing earnings quality, strengthening cash generation, and accelerating progress on deleveraging.”
Scott Richardson, president and chief executive officer
Celanese Leadership Change
Celanese Corporation announced that Anne P. Noonan, who was previously elected to the Board of Directors, has been appointed to the Compensation and Management Development Committee and the Nominating and Corporate Governance Committee. These committee appointments were effective as of October 15, 2026.